# PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.

> **NCT07095205** · PHASE4 · RECRUITING · sponsor: **Stony Brook University** · enrollment: 14 (estimated)

## Conditions studied

- Major Depressive Disorder (MDD)

## Interventions

- **DRUG:** Nicotine transdermal patch
- **DRUG:** PET Scan with [18F] VAT

## Key facts

- **NCT ID:** NCT07095205
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-03
- **Primary completion:** 2029-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07095205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07095205, "PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07095205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*